CRISPR/Cas9内源标记在药物发现中的应用
CRISPR/Cas9 Endogenous Tagging in Drug Discovery
生物技术与制药领域的最新动态
CRISPR/Cas9 Endogenous Tagging in Drug Discovery
Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference - Business Wire
Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference - Barchart.com
Agilent (NYSE: A) schedules Jan. 13 J.P. Morgan Healthcare Conference presentation - Stock Titan
Chronic pain biotech Ambros Therapeutics emerges with $125M and Vivek Ramaswamy on board
‘Zombie’ biotech buyer Xoma to acquire Generation Bio
Aeovian gets $55M for tuberous sclerosis complex, to explore prospects in obesity
5 CDER directors in one year? Turnover threatens ‘institutional memory’ at US health agencies.
Onco3r Therapeutics divulges new TP53 stabilizers
Hangzhou Baicreat Pharma-Tech describes new PTPN1 and PTPN2 inhibitors
Aurora kinase B inhibitors disclosed in Nippon Shinyaku patent
Chinese scientists discover new C5aR antagonists
Other news to note for Dec. 16, 2025
RTW startup signs autoimmune antibody pact with China’s GenSci
FDA extends decision on Aldeyra's dry eye disease drug
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq
Waters Corporation $WAT Shares Sold by Armstrong Henry H Associates Inc. - MarketBeat
Aaron Wealth Advisors LLC Acquires 2,480 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Cell Free DNA Testing Market Is Going to Boom |• Illumina • Guardant Health - openPR.com
Sanofi signs $1B biobucks pact for Alzheimer’s asset in 2nd biotech deal of the day